Loco-Regional Therapy for HCC - Benjamin Sarkodie

Conference on Liver Disease in Africa (COLDA) 2019

Surgical Therapy for HCC--Including Resection and Liver Transplantation - Mahmoud El-Meteini

Conference on Liver Disease in Africa (COLDA) 2019

Improving Risk Stratification and Early Detection of HCC in Africa - Ashraf Omar

Conference on Liver Disease in Africa (COLDA) 2019

Epidemiology, Burden of Disease and Outcomes of HCC in Africa - Edith Okeke

Conference on Liver Disease in Africa (COLDA) 2019

Viral Hepatitis and Pregnancy - Wendy Spearman

Conference on Liver Disease in Africa (COLDA) 2019

What's New in Viral Hepatitis--Including EASL Coverage - Thomas Berg

Conference on Liver Disease in Africa (COLDA) 2019

Keynote Lecture: Global Efforts on Viral Hepatitis Elimination - John Ward

Conference on Liver Disease in Africa (COLDA) 2019

Hepatitis Function of Illicit Drugs Users: A cross-sectional study in Yaounde-Cameroon

Conference on Liver Disease in Africa (COLDA) 2019

In African livers also, steatosis is a frequent background for cancer

Conference on Liver Disease in Africa (COLDA) 2019

Assessment of Vitamin D levels Among chronic Hepatitis B virus population in Khartoum. Sudan

Conference on Liver Disease in Africa (COLDA) 2019

Drug-Induced Acute Liver Failure and Vanishing Bile Duct Syndrome after Levofloxacin Azithromycin combination for the Treatment of Pneumonia

Conference on Liver Disease in Africa (COLDA) 2019

Prevalence of liver function tests abnormality and associated factors among type 2 diabetes mellitus patients: a comparative cross-sectional study

Conference on Liver Disease in Africa (COLDA) 2019

Investigating current gaps and unmet needs in epidemiology practice in the light of rising nash cases in Malawi.

Conference on Liver Disease in Africa (COLDA) 2019

Cancer primitif du foie sur hépatopathies virales B et/ou C au CHU Sourô Sanou.

Conference on Liver Disease in Africa (COLDA) 2019

Erythrocyte sedimentation rate in hepatocellular carcinoma: Are we ignoring a potential bio-marker?

Conference on Liver Disease in Africa (COLDA) 2019

Knowledge and practice on magnitude, diagnosis, treatment and prevention strategies of Hepatocellular Carcinoma in Ethiopia: A Systematic Review

Conference on Liver Disease in Africa (COLDA) 2019

Hepatocellular carcinoma on top of non- alcoholic fatty liver disease started to appear in Egypt

Conference on Liver Disease in Africa (COLDA) 2019

Biochemical and Histopathological Evidence of Anticancer Potentials of Ethanolic Leaves Extract of Diodia Samentosa (SW) Against Diethyl nitrosamine-Induced Hepatocellular Carcinoma in Albino Rats

Conference on Liver Disease in Africa (COLDA) 2019

Vitamin D Receptor Gene Polymorphisms as a Predictive Risk Factor for Hepatocellular Carcinoma Development and Severity in Chronic Hepatitis B

Conference on Liver Disease in Africa (COLDA) 2019

HCC in a prospective cohort of HBV-infected patients in Ethiopia

Conference on Liver Disease in Africa (COLDA) 2019

The Significance of Vitamin D Receptor Gene Polymorphisms for Susceptibility to Hepatocellular Carcinoma in Egyptian Subjects Infected with Hepatitis C Virus

Conference on Liver Disease in Africa (COLDA) 2019

Predictive factors of hepatitis B virus infection related to occurrence of hepatocellular carcinoma in Cameroonian patients

Conference on Liver Disease in Africa (COLDA) 2019

Identification of Cyclase-Associated Protein-2 as a Novel Biomarker for Early-Stage Hepatocellular Carcinoma

Conference on Liver Disease in Africa (COLDA) 2019

Definitive Laboratory Management of HBV/HIV Coinfections in Kenya

Conference on Liver Disease in Africa (COLDA) 2019